Vitroscope
Vitroscope is a biotech company developing perfusion platforms to study immune activity, treatment responses and disease mechanisms in real time.
Vitroscope has raised €6.3M across 1 funding round from 9 investors, most recently a Seed round in Nov 2026. Based in Trondheim, Norway; active in Healthtech. Data as of 3 Nov 2026.
Trondheim, Norwaywww.vitroscope.com ↗
Total raised
€6.3M
€6,261,741
Funding rounds
1
Investors
9
distinct backers
Active since
2026-11
latest 2026-11
Funding by year
EUR raised per year · 2026 YTDVitroscope — funding by year — interactive chart.
Data table
| Vitroscope — funding by year | |
|---|---|
| 2026 | €6.3M |
Signals
High confidenceRaise-next likelihood14
base rate 44% for Seed
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round- 2026-11-03Seed€6.3MAngel Investors,Arcas Ventures,Carles Reina,Cerberus Capital Management+5 more
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-11-03 | Seed | €6.3M | Angel Investors,Arcas Ventures,Carles Reina,Cerberus Capital Management,Devico Invest,Fàtima Godall+3 more | View deal → |
Investors
9Related news
Similar companies
same sector, similar size- Uncovr€6.1MFrance · Healthtech
- Neurosoft Bioelectronics€6.5MSwitzerland · Healthtech
- CollimateHealth€6.0MGermany · Healthtech
- Avenue Biosciences€7.2MFinland · Healthtech
- Stride€5.5MUK · Healthtech
- XRlabs€7.5MUK · Healthtech
Global coverage: FundingData